National Health Investors Future Growth
Future criteria checks 2/6
National Health Investors is forecast to grow earnings and revenue by 10.8% and 13.7% per annum respectively. EPS is expected to grow by 5% per annum. Return on equity is forecast to be 9.1% in 3 years.
Key information
10.8%
Earnings growth rate
5.0%
EPS growth rate
Health Care REITs earnings growth | 22.3% |
Revenue growth rate | 13.7% |
Future return on equity | 9.1% |
Analyst coverage | Good |
Last updated | 10 Dec 2024 |
Recent future growth updates
Recent updates
National Health Investors: Back To 5% Yield Spells Buying Opportunity
Dec 12National Health Investors: From Struggles To Strength
Sep 29National Health Investors: The Lack Of Upside Seems Obvious To Me Here
May 09National Health: Lots To Love, But Valuation Still On The High Side
Feb 23Catch The Senior Housing Rebound With National Health Investors
Nov 27National Health Investors: 7% Yielding REIT Has Improved On Most Metrics
Nov 13National Health Investors: Enjoy This Solid 7%+ Yield, For Now
Aug 30National Health: What We Got Wrong With This Healthcare REIT
Jun 14National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M
Feb 216%-Yielding National Health Investors: No Pain, No Gain
Feb 06National Health Investors: Why This 5.5%-Yielding Rebound Is Worth A Shot
Sep 10Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 400 | 165 | N/A | N/A | 4 |
12/31/2025 | 350 | 148 | N/A | N/A | 6 |
12/31/2024 | 325 | 130 | N/A | N/A | 4 |
9/30/2024 | 330 | 127 | 199 | 203 | N/A |
6/30/2024 | 327 | 128 | 201 | 204 | N/A |
3/31/2024 | 320 | 132 | 191 | 194 | N/A |
12/31/2023 | 320 | 136 | 181 | 184 | N/A |
9/30/2023 | 311 | 105 | 176 | 178 | N/A |
6/30/2023 | 307 | 110 | 170 | 171 | N/A |
3/31/2023 | 290 | 92 | 177 | 178 | N/A |
12/31/2022 | 279 | 66 | 185 | 185 | N/A |
9/30/2022 | 278 | 71 | 192 | 192 | N/A |
6/30/2022 | 275 | 68 | 198 | 198 | N/A |
3/31/2022 | 289 | 85 | 193 | 193 | N/A |
12/31/2021 | 297 | 112 | 211 | 211 | N/A |
9/30/2021 | 307 | 142 | 213 | 213 | N/A |
6/30/2021 | 317 | 154 | 224 | 224 | N/A |
3/31/2021 | 327 | 159 | 232 | 232 | N/A |
12/31/2020 | 330 | 185 | 232 | 232 | N/A |
9/30/2020 | 332 | 190 | 233 | 233 | N/A |
6/30/2020 | 330 | 190 | 231 | 231 | N/A |
3/31/2020 | 325 | 186 | 224 | 224 | N/A |
12/31/2019 | 318 | 160 | 241 | 241 | N/A |
9/30/2019 | 310 | 155 | 236 | 236 | N/A |
6/30/2019 | 303 | 154 | 233 | 233 | N/A |
3/31/2019 | 298 | 152 | 233 | 233 | N/A |
12/31/2018 | 295 | 154 | 208 | 208 | N/A |
9/30/2018 | 292 | 155 | 208 | 208 | N/A |
6/30/2018 | 288 | 153 | N/A | 205 | N/A |
3/31/2018 | 285 | 154 | N/A | 198 | N/A |
12/31/2017 | 279 | 159 | N/A | 198 | N/A |
9/30/2017 | 273 | 163 | N/A | 194 | N/A |
6/30/2017 | 264 | 157 | N/A | 189 | N/A |
3/31/2017 | 255 | 163 | N/A | 185 | N/A |
12/31/2016 | 247 | 152 | N/A | 177 | N/A |
9/30/2016 | 240 | 165 | N/A | 173 | N/A |
6/30/2016 | 235 | 165 | N/A | 168 | N/A |
3/31/2016 | 230 | 152 | N/A | 167 | N/A |
12/31/2015 | 227 | 149 | N/A | 164 | N/A |
9/30/2015 | 215 | 122 | N/A | 154 | N/A |
6/30/2015 | 201 | 114 | N/A | 145 | N/A |
3/31/2015 | 190 | 108 | N/A | 136 | N/A |
12/31/2014 | 177 | 102 | N/A | 126 | N/A |
9/30/2014 | 165 | 98 | N/A | 123 | N/A |
6/30/2014 | 151 | 95 | N/A | 118 | N/A |
3/31/2014 | 134 | 88 | N/A | 109 | N/A |
12/31/2013 | 118 | 78 | N/A | 104 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NHI's forecast earnings growth (10.8% per year) is above the savings rate (2.6%).
Earnings vs Market: NHI's earnings (10.8% per year) are forecast to grow slower than the US market (15.2% per year).
High Growth Earnings: NHI's earnings are forecast to grow, but not significantly.
Revenue vs Market: NHI's revenue (13.7% per year) is forecast to grow faster than the US market (9.1% per year).
High Growth Revenue: NHI's revenue (13.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NHI's Return on Equity is forecast to be low in 3 years time (9.1%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 01:53 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
National Health Investors, Inc. is covered by 20 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
John Kim | BMO Capital Markets Equity Research |
Richard Anderson | BMO Capital Markets U.S. (Historical) |
Joshua Dennerlein | BofA Global Research |